Chronic Constipation Market Growth Anticipated: Chronic Constipation Set for Robust Expansion upto 2032, Major Players Include Kissei Pharmaceutical Co., Ltd., Wecare Probiotics Co., Ltd., Astellas Pharma Inc

(Delhi, India) In the market landscape of Chronic Constipation, an impressive surge is expected during the study period spanning 2019 to 2032, according to latest report titled “Chronic Constipation Market Insights, Epidemiology and Market Forecast, 2032” from DelveInsight. Noteworthy advancements are projected, fueled not only by existing approved therapies but also by the introduction of emerging treatments slated for launch between 2023 and 2032, incremental increase in incidence is reported to impact market significantly.

The report sheds light on Chronic Constipation current treatment practices, upcoming drugs in the Chronic Constipation pipeline, market shares of individual therapies, and the anticipated trajectory of the Chronic Constipation market size from 2019 to 2032 across the 7MM (the United States, the EU-4 comprising Italy, Spain, France, and Germany, the United Kingdom, and Japan).

Driving Forces Behind the Chronic Constipation Market Growth

The robust expansion of the Chronic Constipation market is propelled by a confluence of factors, reflecting a dynamic landscape that spans therapeutic innovations, demographic trends, and evolving treatment paradigms. 

Discover the Anticipated Evolution and Growth of the Market @ Chronic Constipation Therapeutics Market Forecast

Therapeutic Advancements and Emerging Treatments:

• Chronic Constipation Clinical Trial Progression: The market is set to experience significant growth, driven by the progression of emerging therapies expected for launch between 2023 and 2032. Pioneering companies, including Kissei Pharmaceutical Co., Ltd., Wecare Probiotics Co., Ltd., Astellas Pharma Inc, and others, are actively engaged in developing novel drugs for potential market entry.
• Chronic Constipation Innovative Therapies: Ongoing research and development activities are fostering the introduction of innovative therapies designed to address the signs and symptoms of Chronic Constipation. Naronapride, and other emerging therapies such as Linaclotide, KWA-0711, ASP0456, Tegaserod, AJG555, RM-131, Prucalopride, TD-5108, PEG 4000, prucalopride, Lubiprostone, and others are giving positive topline results, in their clinical trials.

Chronic Constipation Epidemiological Trends and Patient Demographics:

·   Increasing Prevalence and awareness: The rising incidence of Chronic Constipation is influenced by factors such as lifestyle changes. These factors contribute to an expanding patient pool, creating a growing market for pharmaceuticals and treatments related to chronic constipation.

Market Awareness and Healthcare Professional Engagement:

·   Growing Awareness: The Chronic Constipation market is witnessing a surge in awareness among both healthcare professionals and patients. Early diagnosis and intervention are becoming more prevalent, shaping a proactive approach to managing the condition.

Report Features

Geography Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

Study Period: 2019-2032

Market Size: USD XX Million in 2021

Key Companies: Kissei Pharmaceutical Co., Ltd., Wecare Probiotics Co., Ltd., Astellas Pharma Inc., and others.

Leading Chronic Constipation Companies and Emerging Drugs: Pioneering companies such as Kissei Pharmaceutical Co., Ltd., Wecare Probiotics Co., Ltd., Astellas Pharma Inc, among others, are actively developing novel drugs for potential entry into the Chronic Constipation market.

Chronic Constipation Therapeutic Landscape: Key therapies identified for Chronic Constipation treatment include Linaclotide, KWA-0711, ASP0456, Tegaserod, AJG555, RM-131, Prucalopride, TD-5108, PEG 4000, prucalopride, Lubiprostone, Naronapride, and more.

Chronic Constipation Overview:

movements or difficulty passing stools for an extended period. It's a common issue affecting people of all ages, but it's particularly prevalent among the elderly. Chronic constipation can significantly impact a person's quality of life and overall health if left untreated.

Chronic Constipation Symptoms:

Fewer Bowel Movements: Typically, fewer than three bowel movements per week.

Difficulty Passing Stools: Straining during bowel movements or experiencing a sensation of incomplete evacuation.

Hard Stools: Stools are usually hard, dry, and difficult to pass.

Abdominal Discomfort: Pain, cramping, or bloating in the abdominal area may occur.

Feeling of Blockage: Sensation of blockage in the rectum preventing bowel movements.

Rectal Bleeding: Due to straining or passing hard stools, this may occur occasionally.

Chronic Constipation Causes:

Dietary Factors: Low fiber intake, inadequate hydration, excessive consumption of dairy or processed foods, ignoring the urge to have a bowel movement.

Causes of Lack of physical activity, sedentary lifestyle, ignoring the need to go to the bathroom, changes in routine or travel disrupting bowel habits.

Medications: Certain medications (such as opioids, some antidepressants, antacids containing aluminum or calcium) can contribute to constipation.

Underlying Medical Conditions: Conditions like irritable bowel syndrome (IBS), diabetes, hypothyroidism, or neurological disorders can lead to chronic constipation.

Structural Issues: Bowel obstruction, colorectal cancer, pelvic floor dysfunction, or other structural abnormalities can cause chronic constipation.

Key Facts Chronic Constipation Market Report:

• The Chronic Constipation market size is anticipated to grow with a significant CAGR during the study period (2019-2032).
• According to Yamamoto et al. (2022), in an online survey conducted in the USA, the prevalence of chronic constipation was reported to be 5.5% according to the Rome III criteria, and it was found to be 2.1%based on medical consultations in Japan.
• According to the Comprehensive Survey of Living Conditions in Japan (2017), constipation is more prevalent in women than in men. However, the number of men with constipation increases at the age of> 70 years, with approximately equal occurrence at the age of ≥80 years.

Chronic Constipation Epidemiology Segmentation:

The Chronic Constipation market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Chronic Constipation

• Prevalent Cases of Chronic Constipation by severity

• Gender-specific Prevalence of Chronic Constipation

• Diagnosed Cases Chronic Constipation

Chronic Constipation Treatment & Market Dynamics:

Lifestyle Changes: Increasing fiber intake, staying hydrated, regular exercise, and establishing a routine for bowel movements.

Dietary Modifications: Adding more fruits, vegetables, whole grains, and fiber-rich foods to the diet.

Medications: Laxatives, stool softeners, or other over-the-counter medications can help manage chronic constipation. However, their prolonged use should be under medical supervision.

Biofeedback Therapy: For cases related to pelvic floor dysfunction.

Prescription Medications: In some cases, prescription medications might be necessary, especially for specific underlying medical conditions.

Market Dynamics and Challenges:

The dynamic landscape of the chronic constipation market is influenced by increased incidence owing to lifestyle changes. Research and development activities are on the rise, reflecting a growing awareness of the condition among healthcare professionals and patients.

DelveInsight's comprehensive report provides a thorough exploration of the chronic constipation market, covering key players, emerging therapies, treatment dynamics, and market challenges.

For in-depth insights, access the full report @ Chronic Constipation Market Outlook 2032

About DelveInsight:

DelveInsight is a prominent business consultant and market research firm specializing in the life sciences sector. With a focus on supporting pharmaceutical companies, DelveInsight provides end-to-end solutions to enhance their performance.

Related Reports:

Chronic Constipation Epidemiology Forecast

Chronic Constipation Epidemiology Forecast report delivers an in-depth understanding of the Chronic Constipation, historical and forecasted epidemiology in the United States, the EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic Idiopathic Constipation Pipeline Insight

Chronic Idiopathic Constipation Pipeline Insight report provides comprehensive insights about companies and pipeline drugs in the Chronic Idiopathic Constipation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. 

Healthcare Consulting and Market Research Services by DelveInsight

Upgrade your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics @ Healthcare Market Research Services

About DelveInsight:

DelveInsight is a prominent business consultant and market research firm specializing in the life sciences sector. With a focus on supporting pharmaceutical companies, DelveInsight provides end-to-end solutions to enhance their performance.

Connect with DelveInsight:

LinkedIn | Facebook | Twitter

Contact Us:

Kritika Rehani

krehani@delveinsight.com

+91-9650213330

www.delveinsight.com